GITEX GLOBAL 2025 Day 3: The rise of digital health, biotech and AI-powered sciences
M42, Cleveland Clinic, SandboxAQ, Mammoth Biosciences and Paradromics lead the conversations on AI discoveries, health intelligence and brain-computer interfaces.
M42’s ADHDS launches the Jordan Digital Health Center (Virtual Hospital) in Jordan in partnership with G42’s Presight and Jordanian government ministries
Jordan's first Digital Health Center connects five remote hospitals to a central command center in Alsalt, a city in west-central Jordan.
Expand North Star 2025 by GITEX GLOBAL opens, celebrating ten years of startup innovation with its biggest edition ye
Expand North Star showcases the most disruptive solutions and projects spanning industries including digital health.
From stethoscope to smartphone: How Vitome is redefining heart screening
In an interview with HealthTechAsia, Vitome CEO Prof Joshua Ho explains how Vitogram turns a phone mic into a heart-monitoring tool.
How Kazakhstan’s University Medical Center is using AI to advance cardiac surgery in Central Asia
Pioneering surgeon Dr. Yuriy Pya shares insights on advancing heart surgery in Central Asia — from TAVI to AI.
Global tech leaders unite to propel emerging future-critical sectors at GITEX GLOBAL 2025
This year's edition of GITEX Global will highlight significant developments in biotech, physical AI, quantum computing, semiconductors, and data centres.
Saudi Arabia’s health data regulations: ensuring privacy, segregation, and breach notification
Saudi Arabia's regulatory approach enables healthcare providers to safeguard patient information, mitigate legal risks, and foster trust in the evolving digital health landscape, BSA Law's Jana Mrad highlights.
Cleveland Clinic Abu Dhabi signs agreement to pilot innovative surgical platform Polyphonic
Cleveland Clinic Abu Dhabi will integrate Polyphonic into three of its operating rooms for one year, focusing on minimally invasive and robotic-assisted procedures.
Mediwhale eyes 2025 Saudi launch of AI retinal imaging for heart disease
Korean company Mediwhale is redefining heart disease detection with retinal biomarkers and AI. In a HealthTechAsia interview, they share global expansion plans and upcoming solutions.